◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Torrent Pharmaceuticals Limited (TORNTPHARM) Free Cash Flow 2022–2026
DATA UPDATED 2026-09-20
Torrent Pharmaceuticals Limited annual free cash flow for fiscal 2026 was ₹23.5 billion, an increase of 18.9% from ₹19.7 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
TORNTPHARM Annual Free Cash Flow
| Free Cash Flow (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|
| Free Cash Flow | ₹23.5B | ₹19.7B | ₹28.3B | ₹17.9B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Free Cash Flow at Comparable Companies
More TORNTPHARM metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS
All TORNTPHARM financial statements → Interactive TORNTPHARM charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.